A Phase 1/1b Study of IAM1363 in HER2 Cancers
Iambic Therapeutics, Inc
Iambic Therapeutics, Inc
National Cancer Institute (NCI)
Stemline Therapeutics, Inc.
Wake Forest University Health Sciences
NRG Oncology
Mayo Clinic
Institut Cancerologie de l'Ouest
Weill Medical College of Cornell University
InSightec